Evidence map›Paper›PMID 33139970›Full record

ArticleCEUR workshop proceedings2014

Towards a foundational representation of potential drug-drug interaction knowledge.

Mathias Brochhausen, Jodi Schneider, Daniel Malone, Philip E Empey, William R Hogan, Richard D Boyce

Abstract read
In one paragraph

Article in CEUR workshop proceedings, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The use of foundational ontologies in biomedical research.Journal of biomedical semantics · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Adding evidence type representation to DIDEO.CEUR workshop proceedings · 2016
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mathias BrochhausenDivision of Biomedical Informatics, University of Arkansas for Medical Sciences, 4301 W. Markham St., #782, Little Rock, AR, 72205-7199.
Jodi SchneiderWeb-instrumented man-machine interactions, communities and semantics group, INRIA Sophia Antipolis - Méditerranée, France.
Daniel MaloneCollege of Pharmacy, University of Arizona, Tucson, AZ, USA.
Philip E EmpeyDepartment of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.
William R HoganDepartment of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville, FL, USA.
Richard D BoyceDepartment of Biomedical Informatics, University of Pittsburgh,, Pittsburgh, USA.

Funding

University of Pittsburgh Clinical and Translational Science InstitutionKL2TR000146 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$8.7M
Addressing gaps in clinically useful evidence on drug-drug interactionsR01LM011838 · NLM · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BOYCE, RICHARD DAVID · 2014 to 2017
$1.6M
Improving medication safety for nursing home residents prescribed psychotropic drK01AG044433 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BOYCE, RICHARD DAVID · 2014 to 2016
$342k
AHRQ HHS R13 HS021826NCATS NIH HHS KL2 TR000146NIA NIH HHS K01 AG044433NLM NIH HHS R01 LM011838
6 · The paper itself

Abstract

Inadequate representation of evidence and knowledge about potential drug-drug interactions is a major factor underlying disagreements among sources of drug information that are used by clinicians. In this paper we describe the initial steps toward developing a foundational domain representation that allows tracing the evidence underlying potential drug-drug interaction knowledge. The new representation includes biological and biomedical entities represented in existing ontologies and terminologies to foster integration of data from relevant fields such as physiology, anatomy, and laboratory sciences.

Indexed as

knowledge managementontologiesPotential drug-drug interactions

Identifiers

PMID33139970
PMCPMC7603806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.